← Alle mensen

BF

Bente Frimodt-Moller

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

RELAY: Final Totale overleving for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-04

RELAY subgroepanalyse naar EGFR-mutatietype: ramucirumab plus erlotinib bij NSCLC

Clinical cancer research : an official journal of the American Association for Cancer Research · 1 oktober 2021

Ramucirumab plus erlotinib bij onbehandeld EGFR-gemuteerd NSCLC: RELAY fase III

The Lancet. Oncology · 2019-12